Status:
COMPLETED
Epidemiology of Thromboembolism Disease: A Cohort Study
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Sanofi
Ministry of Health, France
Conditions:
Vascular Diseases
Embolism and Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine different risk factors of thromboembolic disease. Different points will be studied 1. do different types of thromboembolic disease (distal Deep Vein Thrombos...
Detailed Description
The OPTIMEV study is a prospective epidemiological multicenter cohort study, including in-and outpatients clinically suspected of thromboembolic disease. Deep vein thrombosis is diagnosed using a dupl...
Eligibility Criteria
Inclusion
- patient aged more than 18
- male or female
- patients with clinical thromboembolic signs (deep vein thrombosis or pulmonary embolism)
Exclusion
- patient less than 18 years old
- patient unable to understand
- patient who refused to participate
Key Trial Info
Start Date :
November 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
8256 Patients enrolled
Trial Details
Trial ID
NCT00670540
Start Date
November 1 2004
End Date
February 1 2010
Last Update
May 8 2012
Active Locations (231)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital ND des Bruyeres Liege
Chênée, Belgium
2
General Hospital
Abbeville, France
3
Office-based Specialist in vascular medecine
Albertville, France, 73200
4
Office-based Specialist in vascular medecine
Albi, France, 81000